UCL has announced the launch of a Global Business School for Health, with an aim to address challenges in the health sector and train a new generation of students in healthcare management and leadership.
The programme will explore issues such as labour shortages and gender inequality in leadership, as well as other challenges around the pandemic. It will also include topics such as ageing populations, increases in non-communicable diseases, inefficiencies, gender inequalities in leadership, and rising costs.
Professor Nora Colton, Director of the UCL GBSH, UCL East campus, said: “This is where business schools need to go. Healthcare management is the future and we need professionals in the health sector who can harness diversity in ways to make meaningful change. We have to think about all those people who can’t afford healthcare – they are often the people who need it most.
“This school is a professional school with world-class academics. We want to build the bridges between the public and private health sector to find solutions. This school will be more than just the first, but the best.”
The business school said it “aims to increase the global impact of healthcare delivery and transform healthcare access, experience, and outcomes” and develop “healthcare management leaders of the future through high-quality education”.
Dr Michael Spence, UCL President & Provost, added: “UCL is driven by our mission to solve the world’s most pressing issues so I am proud to announce that we are the first university to launch a new business school dedicated purely to global health.
“With healthcare systems facing unprecedented global challenges such as growing inequality and a rise in non-communicable diseases, I can think of no better time for us to be equipping the next generation of healthcare professionals with the skills to meet these.”
The school will offer short courses, executive education, and online and Master’s programmes, including Health Policy and Practice, an MSc in Digital Health and Entrepreneurship, and an MBA Health. The first cohort will begin in 2022.